seed
Stage
2019
Founded
2
Investors
About
Develops a blood-based diagnostic test for early detection of Autism Spectrum Disorder (ASD), aiming to identify ASD in children as young as 18 months.
Explore BioROSA Technologies Inc.'s full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.